Long-term Therapy With Tenofovir Is Effective for Patients Co-Infected With Human Immunodeficiency Virus and Hepatitis B Virus

Vries-Sluijs, Theodora E. M. S. de; Reijnders, Jurriën G.P.; Hansen, Bettina E.; Zaaijer, Hans L.; Prins, Jan M.; Pas, Suzan D.; Schutten, Martin; Hoepelman, Andy I. M.; Richter, Clemens; Mulder, J.; Man, Rob A. de; Janssen, Harry L.A.; Ende, Marchina E. van der

doi:10.1053/j.gastro.2010.08.045

Cited by 116 publications

(110 citation statements)

References 32 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…More than 95% of patients have undetectable HBV DNA after 5 yr of tenofovir therapy (de Vries-Sluijs et al 2010). It has a high genetic barrier for the development of resistance mutations to HBV.…”

Section: Patients With Coinfection With Hiv and Hcv Hbv And Hiv Coinfmentioning

confidence: 99%

Management of Chronic Hepatitis B in Patients from Special Populations

Lai

Yuen

2015

Cold Spring Harbor Perspectives in Medicine

View full text Add to dashboard Cite

Section: Patients With Coinfection With Hiv and Hcv Hbv And Hiv Coinfmentioning

confidence: 99%

Management of Chronic Hepatitis B in Patients from Special Populations

Lai

Yuen

2015

Cold Spring Harbor Perspectives in Medicine

View full text Add to dashboard Cite

“…Adding tenofovir to the treatment regimen is one of the most promising strategies in such cases, as the antiviral efficacy of tenofovir is not influenced by the presence of lamivudine resistance (20). The introduction of tenofovir and emtricitabine into the HBV armamentarium for HBV/HIVcoinfected patients provides another treatment option (4).…”

Section: Discussionmentioning

confidence: 99%

Hepatitis B e Antigen and Hepatitis B Surface Antigen Seroclearance with the Emergence of Lamivudine-associated and Core Mutations Following CD4 Elevation in a Patient with Hepatitis B and HIV

et al. 2015

View full text Add to dashboard Cite

Obtaining a better understanding of the mechanisms associated with hepatitis B surface antigen (HBsAg) and hepatitis B e antigen (HBeAg) loss in patients with hepatitis B virus (HBV) is important for treating patients with chronic hepatitis B. We herein describe the case of a patient with HBV and human immunodeficiency virus whose chronic hepatitis was stabilized due to HBe and HBs seroconversion with the emergence of lamivudine-associated and core mutations after CD4 elevation. A full-length HBV DNA analysis indicated that HBsAg had been lost after the development of the rtS143T mutation, which corresponded to the emergence of the sF134L and core mutations. The details of this case shed some light on the mechanisms associated with HBsAg and HBeAg clearance.

show abstract

“…ART'nin de birlikte kullanılacağı HBV ve HIV ile ikili infeksiyonu olan olguların tedavisinde TDF ile birlikte ETC yeğlenmelidir. Yine TDF ile birlikte LAM da bir diğer seçeneği oluşturur (51). ETV, böbrek toksisitesi nedeniyle TDF alamayanlarda etkili bir ART'nin yanına ek olarak verilmelidir (52).…”

Section: Hbv Ve Hiv Koinfeksiyonunda Tedaviunclassified

Management of Chronic Hepatitis in Special Hosts and Special Situations: A Consensus Report of the Study Group for Viral Hepatitis of the Turkish Society of Clinical Microbiology and Infectious Diseases

Mıstık¹,

Aydın²,

Aksoy³

et al. 2015

Klimik Dergisi

View full text Add to dashboard Cite

ÖzetTürk Klinik Mikrobiyoloji ve İnfeksiyon Hastalıkları Derneği Viral Hepatit Çalışma Grubu, özel konaklarda ve özel durumlarda kronik hepatit yönetimine ilişkin bir uzlaşı raporu hazırlamak üzere bir toplantı düzenlemiştir. Raporda konuyla ilgili literatür ve uluslararası kılavuzlar, hepatit B virusu (HBV) için sırasıyla kompanse ve dekompanse sirozlu hastalarda kronik hepatit B (KHB) tedavisi, karaciğer nakli sonrası HBV infeksiyonunun nüks etmesinden korunma ve nüks gelişen hastalarda tedavi, fülminan hepatit B tedavisi, hemodiyaliz hastalarında KHB teda- AbstractStudy Group for Viral Hepatitis of the Turkish Society of Clinical Microbiology and Infectious Diseases convened a meeting to develop a consensus report on management of chronic hepatitis in special hosts and special situations. Relevant literature and international guidelines were reviewed, and recommendations agreed are presented at the end of each section such as therapy of chronic hepatitis B (CHB) in patients with compensated and decompensated cirrhosis, prevention and therapy of recurrent hepatitis B after liver transplantation, management of fulminant

show abstract

Long-term Therapy With Tenofovir Is Effective for Patients Co-Infected With Human Immunodeficiency Virus and Hepatitis B Virus

Cited by 116 publications

References 32 publications

Management of Chronic Hepatitis B in Patients from Special Populations

Management of Chronic Hepatitis B in Patients from Special Populations

Hepatitis B e Antigen and Hepatitis B Surface Antigen Seroclearance with the Emergence of Lamivudine-associated and Core Mutations Following CD4 Elevation in a Patient with Hepatitis B and HIV

Management of Chronic Hepatitis in Special Hosts and Special Situations: A Consensus Report of the Study Group for Viral Hepatitis of the Turkish Society of Clinical Microbiology and Infectious Diseases

Contact Info

Product

Resources

About